NPHC — Nutra Pharma Balance Sheet
0.000.00%
HealthcareHighly SpeculativeMicro Cap
- $7.10m
- $16.21m
- $0.59m
Annual balance sheet for Nutra Pharma, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 0 | 0 | 0.091 | 0 | 0.035 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 0.032 | 0.04 | 0.325 | 0.247 | 0.229 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 0.058 | 0.055 | 0.534 | 0.334 | 0.314 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 0.214 | 0.159 | 0.139 | 0.332 | 0.192 |
| Other Long Term Assets | |||||
| Total Assets | 0.34 | 0.302 | 0.78 | 0.755 | 0.64 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 11 | 11.5 | 21.1 | 12.7 | 14.2 |
| Long Term Debt | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 12 | 11.8 | 21.7 | 13.1 | 14.4 |
| Non Redeemable Preferred Stock | |||||
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Total Equity | -11.7 | -11.5 | -20.9 | -12.4 | -13.8 |
| Total Liabilities & Shareholders' Equity | 0.34 | 0.302 | 0.78 | 0.755 | 0.64 |
| Total Common Shares Outstanding | |||||
| Total Preferred Shares Outstanding |